Hand Exoskeleton Training Study
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Medstar Health Research Institute
- Study ID
- NCT06786858
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HandMate — DEVICEHandMate device is used for 20 hours in 4 weeks. Device is then used in the home for 3 months at discretion of participant.
Study Details
The goal of this study is to evaluate the HandMATE device's effectiveness in the rehabilitation of stroke patients and asses if the HandMATE application is received well by stroke survivors. Participants will use the HandMate device in clinic and in the home. They will also complete clinical upper extremity assessments.
Key Dates
- Start date
- Jan 4, 2022
- Status verified
- Jan 2025
- Primary completion
- Jan 4, 2024
- Completion
- Jan 31, 2025
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: HandMate UseHandMate device fitted for a stroke participant.
Primary Outcome Measure
Fugl-Meyer Upper Extremity (FMA-UE) Test [ Time Frame: Change from baseline Fugl-Meyer score at 6 weeks ]
Central Contacts
- Megan L Grainger2028771464
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MedStar National Rehabilitation Hospital | Washington D.C. | District of Columbia | 20010 |
Find similar trials in Washington D.C., DC
By condition
By specialty
By research site
Related Studies
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield TrialsRecruiting · University of Cincinnati · Birmingham, Alabama
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance ImagingRecruiting · Yale University · Birmingham, Alabama